Understanding The JC Virus Testing
Understanding the JC Virus Test In our pursuit to learn more about PML, a blood test (the JC Virus Test)…
Multiple Sclerosis: Monoclonal Antibody Tysabri Reduces Brain Inflammation
MedicalResearch.com Interview with:Jeppe Romme Christensen MD PhDFrom the Danish Multiple Sclerosis CenterCopenhagen University Hospital Hvidovre, Denmark. MedicalResearch.com: What are the…
Stuart Schlossman
HIV Drug May Help in PML
Published: Jan 29, 2014 By John Gever, Deputy Managing Editor, MedPage Today A relatively simple way to make progressive multifocal…
Stuart Schlossman
Antibody Index Test May Aid PML Diagnosis on Natalizumab
Sue Hughes October 30, 2013 COPENHAGEN, Denmark — A new test that compares JC virus (JCV) antibody levels in cerebrospinal fluid (CSF)…
Stuart Schlossman
Test May Suggest Tysabri for More MS Patients
October 7, 2013 COPENHAGEN — A blood test for L-selectin expression on circulating immune cells may identify multiple sclerosis…
Stuart Schlossman
Biogen Idec: New Analyses Show Tysabri Given Earlier Reduces MS Disease Activity
By RTT News, October 03, 2013 (RTTNews.com) – Biogen Idec ( BIIB ) Thursday announced results from several new analyses of…
Stuart Schlossman
Biogen Idec, Elan facing suits over MS drug side effects
New lawsuit rekindles controversy over rare brain disease linked to multiple sclerosis therapy – Business – The Boston Globe Despite…
Stuart Schlossman
Tysabri Screening Test May Be Unreliable
By John Gever, Deputy Managing Editor, MedPage Today Published: June 05, 2013 Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of…
Stuart Schlossman
PML Not Fatal if Caught Early
By John Gever, Senior Editor, MedPage Today Published: March 11, 2013 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of…
Stuart Schlossman
Natalizumab shows promise for teens with multiple sclerosis
February 22, 2013 in Neuroscience (HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according…
Stuart Schlossman
